# Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery

> **NCT01396525** · PHASE3 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 153 (actual)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DEVICE:** Omnilink Elite™ Peripheral Balloon-Expandable Stent System

## Key facts

- **NCT ID:** NCT01396525
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-09
- **Final completion:** 2014-06
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01396525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01396525, "Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01396525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*